You catch it in the bathroom mirror under the worst light in the house — the fluorescent strip that flatters nobody — and there it is. A patch on your cheekbone a shade darker than the rest, plus two smaller ones near your jaw that weren’t there last August. You tilt your head. You lean closer. You wonder, not for the first time, whether it’s gotten bigger, or whether that’s just the lighting.
By midnight you’ve read four articles, watched a fifteen-second video promising to “erase” it, and added three serums to a cart you haven’t checked out yet. That’s roughly where most people start. Worth pausing there, because the ingredient names on those bottles (vitamin C, niacinamide, tranexamic acid, retinol) don’t mean the same thing for every kind of dark spot. Some of it has real evidence behind it. Some of it is expensive water. And one popular answer isn’t legally available on an EU shelf at all, for reasons worth understanding.
Why Spots Show Up in the First Place
Skin colour comes from melanin, made by cells called melanocytes at the base of the epidermis. Under normal conditions they produce a steady amount. Under stress (UV light, inflammation, hormonal shifts, an injury), they can go into overdrive in one spot and leave a patch darker than the skin around it. That’s hyperpigmentation, broadly speaking.
The mechanism is almost always the same kind of signal: something told the melanocytes in that spot to overproduce, and the skin held onto it. What triggered the signal is what actually matters, because the trigger decides what will and won’t fade.
Three Types, and Why the Distinction Decides Everything
This is the part most skincare marketing skips, and it’s the single most useful thing in this article.
Post-inflammatory hyperpigmentation (PIH) follows an injury or inflamed patch of skin — acne that’s cleared up, an eczema flare, a scrape. The melanocytes overreact to the damage and dump extra pigment into the area during recovery. It’s more pronounced and slower to fade in darker skin tones, where the colour sits deeper and lingers longer.
Melasma is a different animal. It shows up as symmetrical, hazy, ill-defined brown-to-grey patches across the cheeks, forehead, nose bridge and upper lip, driven heavily by hormones (pregnancy, oral contraceptives, hormone replacement therapy) layered on UV and visible-light exposure. According to DermNet, roughly 60% of people with melasma report a family history of it, and it concentrates in women aged 20 to 40. It’s notoriously stubborn and prone to relapse, which is why so many people cycle through products for years without lasting results: they’re treating it like a leftover breakout scar, and it isn’t.
Solar lentigines (age spots, sun spots) are flat, well-defined brown marks that build up over years of cumulative UV, typically on the hands, face, chest and shoulders. Unlike melasma, they don’t flare with hormones; unlike PIH, there’s no single injury behind them, just decades outdoors. And here’s the part that matters medically: an “atypical” or changing lentigo can be genuinely hard to tell apart from early melanoma without a dermatologist looking at it directly.
Three mechanisms, three timelines. A “brightening serum” that ignores which one you’re dealing with is guessing.
Pigmentation patterns also shift with age and hormones over a lifetime — part of why what skin needs across your 30s, 40s and 50s can look different even when the visible problem looks the same.
What We Looked At, and Where It Gets Thin
Before writing any of the recommendations below, we went back to the primary literature rather than other brands’ blog posts about it — and the honest picture is more mixed than a product page usually admits.
Some of it holds up well. A Bayesian meta-analysis pooling 31 randomised, vehicle-controlled trials in 741 volunteers found topical vitamin C reliably limits new UV-induced pigmentation, dose-dependently. Solid — but notice what’s being measured: prevention of pigment that hasn’t formed yet, not reversal of a spot already sitting there. Other reviews on existing melasma and lentigines found objective, instrument-measured lightening didn’t always match what patients could see by eye.
Azelaic acid came out better than expected. A 2023 meta-analysis pooling six randomised trials and 673 melasma patients found it produced a statistically significant improvement over hydroquinone on the standard severity scale (mean difference –1.23, P = 0.004), with no meaningful difference in side effects. Six trials isn’t huge, and the authors called for larger, longer ones — but it’s a real signal, not marketing copy.
Oral tranexamic acid, under medical supervision, has a genuinely substantial evidence base for melasma. The topical form is newer territory, promising but less settled. Niacinamide sits lower on the ladder specifically for pigmentation — well documented for barrier support and redness, thinner as a stand-alone depigmenting agent. Alpha arbutin is mechanistically plausible, a tyrosinase inhibitor structurally related to hydroquinone, but its trials run smaller and shorter, and EU safety reviewers flag that it needs monitoring for trace hydroquinone content when formulated alongside hydroquinone-releasing ingredients.
None of that is a reason to give up on actives. It’s a reason to expect realistic things from them.
What the Evidence Supports
| Approach | Strength of evidence | What to realistically expect |
|---|---|---|
| Daily broad-spectrum sunscreen | Very strong; foundational across dermatology guidelines | Won’t fade existing spots alone, but nothing else holds without it — essential, maintained indefinitely |
| Azelaic acid | Solid; meta-analysis of 673 patients, comparable to or slightly better than hydroquinone | Gradual, over roughly 12+ weeks; well tolerated |
| Topical retinoids | Well established, especially in combination; mechanism well understood | Slow, often 3–6 months; can irritate and briefly worsen PIH early on |
| Oral tranexamic acid | Substantial evidence base for melasma, but it’s a prescription medicine | Needs medical supervision and screening for contraindications; not self-started |
| Topical tranexamic acid | Emerging, promising, less settled than the oral form | Early data over 4–8+ weeks; more research needed |
| Vitamin C (topical) | Moderate; strongest for limiting new UV pigment, less consistent on existing spots | Better at prevention than at fading what’s already there |
| Niacinamide | Thinner for pigmentation specifically; stronger for barrier support | A gentle complement, not a headline treatment |
| Alpha arbutin | Thinner; smaller/shorter trials, related mechanism to hydroquinone | Modest, slow; needs care around hydroquinone-related monitoring |
| Hydroquinone | Most effective single agent historically, per dermatology reviews — restricted in the EU (see below) | Under medical supervision: change in 6–12 weeks, capped-duration courses only |
The One Step That Outperforms Everything Else
If you take one thing from this article, take this: consistent daily sun protection does more for hyperpigmentation, over time, than any single active ingredient on this list.
Not exciting advice. Doesn’t sell as a “brightening breakthrough.” But UV and visible light are what push melanocytes into overdrive in the first place, and they undo months of careful treatment in one unprotected afternoon. Dermatology sources are blunt: photoprotection has to be broad-spectrum, high-factor, and kept up year-round, because melasma relapses the moment exposure resumes. Standard sunscreens don’t block visible light well; tinted, iron-oxide formulas do better on that front.
We’re not going to tell you which sunscreen to buy, and we won’t pretend we sell one — we don’t. This is the one piece of advice here with nothing to do with our own product range, and that’s deliberate: it’s the step that matters most, and it’s not one we can sell you.
What to Be Careful With
Here’s where the honest brand link is, and it’s a modest one: a well-formulated routine used every day, for months, alongside sun protection, consistently outperforms an expensive routine used sporadically, almost regardless of which specific actives are involved. It’s the least exciting sentence in this article, and the most defensible one.
QN Europe’s skincare range, Physio Radiance, is developed in Switzerland. On its own product pages, the company describes its Visage+ facial device as offering, among other stated benefits, helps on”lightening of age spots” alongside improvements to fine lines and skin structure — and describes its Expert line as aimed at reducing the appearance of age spots while hydrating and refining texture. If you’re weighing a device against a serum-only routine, see our separate look at what at-home skincare devices can and can’t plausibly do.
Now, the regulatory part, because it’s often misunderstood. Hydroquinone, historically the fastest-acting topical option for stubborn pigmentation, sits on Annex II of Regulation (EC) No 1223/2009, the EU’s list of substances banned from general cosmetic products, as entry 1339. It isn’t legal in an over-the-counter EU cosmetic; the only narrow exception in the regulation covers professional artificial-nail systems, not skincare. Where it’s used at all, it’s typically a prescription item, compounded and supervised by a dermatologist. That’s a different regulatory category entirely from anything sold on a shelf. That restriction exists because unsupervised long-term use carries real risks: a stubborn blue-black discolouration called exogenous ochronosis, and irritant dermatitis that can, ironically, worsen the pigmentation it was meant to fix.
That gap between “banned here” and “still findable somewhere” is where things get dangerous. Products sold outside EU regulatory controls, often through informal online sellers, have repeatedly turned up containing exactly what this framework restricts: uncontrolled hydroquinone, mercury, undisclosed steroids. Anything legally sold in the EU has to comply with the annexes above; a product bought outside that system simply isn’t guaranteed to — not a claim about any particular brand’s formula, just a reason to distrust “guaranteed results” with no visible regulatory footprint. More on how EU cosmetics law works, separately.
The best-reviewed dark-spot ingredient in the world still loses to a bottle of sunscreen nobody reopens after March.
When It’s a Doctor’s Job, Not a Serum’s
A few situations belong to a dermatologist, not a skincare routine.
Melasma is a dermatological diagnosis, not a cosmetic inconvenience. The topical approaches above can help manage its appearance, but a dermatologist should confirm what you’re looking at and rule out other causes, especially alongside a new medication, pregnancy, or a thyroid issue. PIH usually resolves with time, but persistent or unusually dark patches deserve a second opinion, particularly in deeper skin tones where it can linger considerably longer.
And this one matters most: any spot that’s new, changing shape or colour, growing, or behaving differently from the rest of your skin needs a doctor’s evaluation, not a serum. Atypical solar lentigines can be genuinely difficult to distinguish from early melanoma without direct examination, sometimes requiring dermatoscopy or a biopsy. No cosmetic product or device screens for that. Something that looks different than it did three months ago is a dermatology appointment this week, not a shopping decision.
Frequently Asked Questions
How long does it actually take to fade a dark spot?
Longer than the packaging implies. With evidence-supported actives used consistently, most people see early change around 8 to 12 weeks, more meaningful improvement over 4 to 6 months. Melasma can take longer and relapses without ongoing sun protection. Results promised in days are the ad talking, not the biology.
Is hydroquinone worth trying to find anyway?
We’d say no, and not just on legal grounds. Even under medical supervision it’s meant for short, supervised courses, not everyday use — unsupervised long-term use is where the ochronosis and dermatitis risk shows up. Azelaic acid’s evidence looks close enough on effectiveness, with a cleaner safety profile, to be a reasonable place to start instead, ideally discussed with a dermatologist first.
Can I combine several of these actives at once?
Some pairings are reasonably well studied — azelaic acid with a retinoid, vitamin C by day and a retinoid by night. Layering four or five actives at once mostly raises your odds of irritation, and irritation itself can trigger PIH — an overloaded routine working against its own goal.
Does diet or supplements matter here?
The evidence connecting supplements to fading existing spots is thin next to what exists for topicals and sun protection. General skin health is a reasonable background habit, not a substitute for photoprotection or evidence-supported actives.
Is uneven tone the same thing as ageing skin?
Related, not identical. They share triggers, cumulative UV chief among them, but they’re separate processes on separate timelines — part of why a routine built for one life stage doesn’t always fit another.
The Short Version
Dark spots on the face usually come from one of three mechanisms: post-inflammatory hyperpigmentation after injury or inflammation, melasma driven mainly by hormones and light, or solar lentigines from cumulative sun exposure. Which one you have determines what helps. Among topical actives, azelaic acid has the most solid recent trial evidence (a 2023 meta-analysis of 673 patients found it comparable to, or slightly better than, hydroquinone), vitamin C is well supported for preventing new UV-triggered pigment more than reversing existing spots, and niacinamide and alpha arbutin sit on thinner evidence specifically for pigmentation. Hydroquinone remains restricted in general EU cosmetics under Annex II of Regulation (EC) No 1223/2009, available only through supervised medical routes. Across every source reviewed, one point stayed consistent and unglamorous: daily, year-round sun protection is the single highest-leverage step, and nothing else here works reliably without it.
Closing
Strip away the marketing and what’s left is unglamorous: most dark spots respond to the same short list of things — correctly identifying which type you’re dealing with, choosing one or two actives with real evidence behind them, sticking with it for months rather than weeks, and protecting skin from the light that started the problem.
What nobody wants to hear is that the ingredient names matter less than the discipline. A mediocre routine followed every day for six months usually outperforms an excellent one abandoned after three weeks because the results weren’t instant. Not a satisfying thing to build a marketing campaign around, which might be exactly why it doesn’t get said often.
So the next time you’re under that unflattering bathroom light, the more useful question probably isn’t “which serum,” but “which type of spot is this, and am I still willing to be doing this in July.”
Where Our Range Fits
Which is the honest argument for our own products, and the only one we’ll make. Consistency beats ingredient-hunting, and consistency needs a routine short enough that you’ll still be doing it in six months. That’s what Physio Radiance is built for: a Swiss-developed range for healthy ageing, with an Expert line and the Visage+ device for anyone who wants to add a step. The company’s stated benefits for those include reducing the appearance of age spots, and we’d rather you read them as our claims than as guarantees, because pigmentation responds differently for everyone.
Pair any of it with daily sun protection, which we don’t sell and still think matters more than anything on our own shelf. And if you’re not sure which of the three types you’re dealing with, ask a dermatologist first, then come back and build the routine around the answer. Our team can help with that second part.
Written and source-checked by the QN Europe editorial team. We work from peer-reviewed research and stay open about what it doesn’t yet show. Have a question, or your own experience with this? Write to us. We read everything.
